Caravan Biologix

Caravan Biologix develops AI-designed CAR-Directed BioSpheres (Mini-CARs) as allogeneic therapeutic agents that emulate immune cell functions. These miniaturized biospheres offer highly targeted release of apoptotic proteins to treat solid tumors and hereditary diseases with reduced cytotoxicity compared to whole-cell therapies. The platform is available for licensing to develop novel pipelines or enhance existing therapeutic approaches.

Traction 4/10

Princeton, United States · HQ

Founded 20206200+ followers

Biotechnology

Updated 7 months ago

Funding

Raised to date

$2.1MRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.

Funding rounds are not available yet.

Founders

1 founder

Mahmoud Mahmoudian

Chief Executive Officer

Product

Features

Caravan Biologix develops AI-designed CAR-Directed BioSpheres (Mini-CARs) as allogeneic therapeutic agents that emulate immune cell functions. These miniaturized biospheres offer highly targeted release of apoptotic proteins to treat solid tumors and hereditary diseases with reduced cytotoxicity compared to whole-cell therapies. The platform is available for licensing to develop novel pipelines or enhance existing therapeutic approaches.